Clinical Trial Update: Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

View source ↗

Summary

This clinical-trial update describes real-world use of nemolizumab in adults with moderate-to-severe prurigo nodularis and indicates recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Nemolizumab (nemolizumab)

Snippet

Sponsor: Galderma R&D | Conditions: Prurigo Nodularis | Status: RECRUITING